Abstract
Data from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have